Giovanni C Carniel

Title: Giovanni C. Carniel: Innovator in Pharmaceutical Chemistry

Introduction

Giovanni C. Carniel is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target the central nervous system. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Giovanni holds 2 patents that focus on substituted morpholine derivatives. His latest patents include "Substituted morpholine derivatives and pharmaceutical compositions," which disclose compounds such as 2-[.alpha.-(3,4-methylendioxy-phenoxy)-benzyl]-morpholine. These compounds are recognized for their potential use as antidepressant agents. Another patent, "Substituted morpholine derivatives and compositions," features the compound 2-[.alpha.-(2-methoxy-phenoxy)-benzyl]-morpholine, also aimed at central nervous system applications.

Career Highlights

Giovanni is currently associated with Farmitalia Carlo Erba S.p.a., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to developing effective treatments for mental health conditions.

Collaborations

Throughout his career, Giovanni has collaborated with esteemed colleagues, including Piero Melloni and Alessandro Rossi. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Giovanni C. Carniel's contributions to pharmaceutical chemistry are noteworthy, particularly in the realm of antidepressant agents. His innovative patents and collaborations reflect his dedication to improving mental health treatments.